Literature DB >> 848969

Should vitiligo be induced in patients after resection of primary melanoma.

A B Lerner, J J Nordlund.   

Abstract

Entities:  

Mesh：

Year:  1977        PMID： 848969

Source DB:  PubMed          Journal:  Arch Dermatol        ISSN： 0003-987X


× No keyword cloud information.
  6 in total

1.  Autoimmune melanocyte destruction is required for robust CD8+ memory T cell responses to mouse melanoma.

Authors:  Katelyn T Byrne; Anik L Côté; Peisheng Zhang; Shannon M Steinberg; Yanxia Guo; Rameeza Allie; Weijun Zhang; Marc S Ernstoff; Edward J Usherwood; Mary Jo Turk
Journal:  J Clin Invest       Date:  2011-04-11       Impact factor: 14.808

2.  Prevalence of choroidal nevus and retinal pigment epithelial alterations in vitiligo patients.

Authors:  Efrat Fleissig; Mor Pavlovksy; Anat Loewenstein; Dinah Zur; Hadas Newman; Shay Keren; Dafna Goldenberg; Efrat Bar-Ilan; Michaella Goldstein
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2018-03-16       Impact factor: 3.117

3.  Vitiligo- and melanoma-associated hypopigmentation: a similar appearance but a different mechanism.

Authors:  O Merimsky; Y Shoenfeld; G Yecheskel; S Chaitchik; E Azizi; P Fishman
Journal:  Cancer Immunol Immunother       Date:  1994-06       Impact factor: 6.968

Review 4.  The clinical significance of antityrosinase antibodies in melanoma and related hypopigmentary lesions.

Authors:  O Merimsky; Y Shoenfeld; P Fishman
Journal:  Clin Rev Allergy Immunol       Date:  1998       Impact factor: 8.667

Review 5.  New perspectives on the role of vitiligo in immune responses to melanoma.

Authors:  Katelyn T Byrne; Mary Jo Turk
Journal:  Oncotarget       Date:  2011-09

6.  Vitiligo-like lesions in a patient treated with nivolumab for renal cell carcinoma.

Authors:  Cristian Lolli; Matelda Medri; Michela Ricci; Giuseppe Schepisi; Alessia Filograna; Ugo De Giorgi; Ignazio Stanganelli
Journal:  Medicine (Baltimore)       Date:  2018-12       Impact factor: 1.817
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.